Menu
GeneBe

rs61755771

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000322.5(PRPH2):c.136C>T(p.Arg46Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

PRPH2
NM_000322.5 stop_gained

Scores

3
3
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:13O:1

Conservation

PhyloP100: 2.15
Variant links:
Genes affected
PRPH2 (HGNC:9942): (peripherin 2) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein found in the outer segment of both rod and cone photoreceptor cells. It may function as an adhesion molecule involved in stabilization and compaction of outer segment disks or in the maintenance of the curvature of the rim. This protein is essential for disk morphogenesis. Defects in this gene are associated with both central and peripheral retinal degenerations. Some of the various phenotypically different disorders are autosomal dominant retinitis pigmentosa, progressive macular degeneration, macular dystrophy and retinitis pigmentosa digenic. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-42722199-G-A is Pathogenic according to our data. Variant chr6-42722199-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-42722199-G-A is described in Lovd as [Pathogenic]. Variant chr6-42722199-G-A is described in Lovd as [Pathogenic]. Variant chr6-42722199-G-A is described in Lovd as [Likely_pathogenic]. Variant chr6-42722199-G-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRPH2NM_000322.5 linkuse as main transcriptc.136C>T p.Arg46Ter stop_gained 1/3 ENST00000230381.7
PRPH2XR_007059288.1 linkuse as main transcriptn.399C>T non_coding_transcript_exon_variant 1/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRPH2ENST00000230381.7 linkuse as main transcriptc.136C>T p.Arg46Ter stop_gained 1/31 NM_000322.5 P1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152112
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000159
AC:
4
AN:
251390
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135894
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461890
Hom.:
0
Cov.:
33
AF XY:
0.00000413
AC XY:
3
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152112
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74292
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000290
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Patterned macular dystrophy 1 Pathogenic:3
Likely pathogenic, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterMar 06, 2023_x000D_ Criteria applied: PVS1, PS4 -
Pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterJan 25, 2022- -
not provided Pathogenic:2Other:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxMay 05, 2021Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32660024, 28559085, 29343940, 29555955, 25447119, 7880786, 11139241, 8111389, 26061163, 25412400, 7825692, 20213611, 28129423, 32531846, 23105016) -
not provided, no classification providedliterature onlyRetina International-- -
Pathogenic, no assertion criteria providedcurationLeiden Open Variation DatabaseApr 29, 2021Curator: Global Variome, with Curator vacancy. Submitters to LOVD: Julia Lopez, LOVD, Manon Peeters, Yoshito Koyanagi. Comment: Variant observed de novo. -
Retinal dystrophy Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingBlueprint GeneticsSep 21, 2018- -
Pathogenic, criteria provided, single submitterresearchDept Of Ophthalmology, Nagoya UniversityOct 01, 2023- -
Stargardt disease Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingNEI Ophthalmic Genomics Laboratory, National Institutes of HealthJan 07, 2020The variant NM_000322.4:c.136C>T in the PRPH2 gene has been previously studied (PMIDs 8111389, 20213611, 23105016, 25412400, 25412400, 28559085, 29555955, 29343940). We found this variant in 2 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755771,CM930635). It is present in gnomAD browser (AF 0.0000163). It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PVS1, PS4, PM2, PP1-M, PP5] and classified NM_000322.4:c.136C>T in the PRPH2 gene as a Pathogenic mutation. -
Pathogenic, no assertion criteria providedresearchOphthalmo-Genetics Lab, Instituto de Oftalmologia Conde de ValencianaDec 13, 2022- -
Patterned dystrophy of the retinal pigment epithelium Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingNEI Ophthalmic Genomics Laboratory, National Institutes of HealthJan 07, 2020The variant NM_000322.4:c.136C>T in the PRPH2 gene has been previously studied (PMIDs 8111389, 20213611, 23105016, 25412400, 25412400, 28559085, 29555955, 29343940). We found this variant in 2 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755771,CM930635). It is present in gnomAD browser (AF 0.0000163). It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PVS1, PS4, PM2, PP1-M, PP5] and classified NM_000322.4:c.136C>T in the PRPH2 gene as a Pathogenic mutation. -
Retinitis pigmentosa 7 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 1995- -
Choroidal dystrophy, central areolar 2 Pathogenic:1
Pathogenic, criteria provided, single submitterresearchCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterMar 17, 2024- -
PRPH2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 02, 2024This sequence change creates a premature translational stop signal (p.Arg46*) in the PRPH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRPH2 are known to be pathogenic (PMID: 8111389, 8485575, 8485576, 8675410, 16916875, 17504850, 22863181, 25675413, 26061163, 27365499, 29555955, 33546218). This variant is present in population databases (rs61755771, gnomAD 0.009%). This premature translational stop signal has been observed in individuals with autosomal dominant retinitis pigmentosa (adRP), macular dystrophy, or cone-rod dystrophy (PMID: 7880786, 8111389, 25447119, 28559085, 29555955). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13179). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.56
Cadd
Pathogenic
37
Dann
Uncertain
1.0
Eigen
Pathogenic
0.70
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.87
D
MutationTaster
Benign
1.0
A
Vest4
0.83
GERP RS
3.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61755771; hg19: chr6-42689937; COSMIC: COSV57837088; API